An evaluation of whole blood testing for Helicobacter pylori infection in the Chinese population by Wong, BCY et al.
Title An evaluation of whole blood testing for Helicobacter pyloriinfection in the Chinese population
Author(s) Wong, BCY; Wong, WM; Tang, VSY; Lai, KC; Yuen, ST; Hu, WHC;Chan, CK; Lau, GKK; Lai, CL; Lam, SK
Citation Alimentary Pharmacology And Therapeutics, 2000, v. 14 n. 3, p.331-335
Issued Date 2000
URL http://hdl.handle.net/10722/48625
Rights Creative Commons: Attribution 3.0 Hong Kong License
This is a pre-published version
  Wong et al. Page  1 
 
 
An Evaluation of Whole Blood Testing for 
Helicobacter pylori infection in Chinese 
 
Benjamin C.Y. Wong*, Wai-Man Wong*, Vera S.Y. Tang, Kam-Chuen Lai, Siu-Tsan 
Yuen#, Wayne HC Hu, Chi-Kuen Chan, George K.K. Lau, Ching-Lung Lai, Shiu-Kum Lam    
 
*Contributed equally to this work 
 
Departments of Medicine and Pathology#, University of Hong Kong, Queen Mary Hospital, 
Pokfulam Road, Hong Kong S.A.R., China.  
 
Abbreviations used in this paper: Helicobacter pylori, H. pylori; 13C-urea breath test, 13C-
UBT;  
 
Address correspondence to: Dr Benjamin CY Wong, Division of Gastroenterology and 
Hepatology, University Department of Medicine, Queen Mary Hospital, Pokfulam Road, 
Hong Kong S.A.R., China.  
 
Telephone       852-28554541 
Fax                 852-28725828 
E-mail            bcywong@hkucc.hku.hk 
Keywords: Helicobacter pylori, whole blood test, urea breath test, histology and CLO test. 
  Wong et al. Page  2 
ABSTRACT   
BACKGROUND : Near patient tests for Helicobacter pylori (H. pylori) were developed to 
assist in the management of dyspepsia patients in general practice. Most studies were 
performed in western population. 
AIM : To evaluate the rapid whole blood test (Flexpack HP) for H. pylori in Chinese 
population.  
METHODS : Consecutive dyspeptic patients referred for upper endoscopy were recruited. 
During upper endoscopy, biopsies were taken from the antrum and corpus for CLO test and 
histological examination. After endoscopy, the whole blood test (FlexPack HP) was 
performed according to the manufacturer's instruction. Patients then received a 13C-urea 
breath test (13C-UBT). Results of the whole blood test were compared with the gold standard 
(CLO test, histology and 13C-UBT). 
RESULTS: 294 consecutive patients gave a valid Flexpack HP result for interpretation. Mean 
age of patients was 47.7 (range 15-85) years. Analysis showed a sensitivity, specificity, 
positive predictive value, negative predictive value and accuracy of 58.2%, 92.2%, 90.6%, 
63.2% and 73.1% respectively. There was no influence by the age of the patient and the 
familiarity of the operators. 
CONCLUSION: The FlexPack HP whole blood test showed good specificity but lacked 
sensitivity. It is not sensitive enough to be used in general practice setting for the test and 
treat approach in Chinese population.  
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INTRODUCTION 
Helicobacter pylori  (H. pylori) infection plays an important role in the pathogenesis of 
peptic ulcer disease and adenocarcinoma of stomach.[1] The development of effective 
antimicrobial therapy for H. pylori was proven to be an effective treatment of peptic ulcer 
disease. The eradication of H. pylori significantly reduced the relapse of peptic ulcers.[2-9] 
Endoscopy is the most reliable method for the diagnosis of peptic ulcer disease and gastric 
cancer. However, majority of patients presenting with dyspepsia has normal endoscopic 
findings. Thus empirical treatment of H. pylori infection in dyspeptic patients remains an 
attractive approach in general practice. It may increase the cost-effectiveness of the 
management of patients with dyspepsia. Rapid whole blood tests for H. pylori infection were 
developed to assist in the management of patients with dyspepsia in general practice. The 
results of these tests are usually available in less than ten minutes. Test and treat approach 
using these kits has been estimated to reduce the demand for endoscopy by 25 to 
37%.[10,11,12] Most of the validation studies performed so far were in non-Chinese 
population. Thus we carried out a prospective study to validate the use of rapid whole blood 
test in Chinese population. 
 
METHODS 
Patient Population 
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Three hundred and seventh Chinese patients referred to the endoscopy unit of Department of 
Medicine, Queen Mary hospital for investigation of dyspepsia were recruited. Dyspepsia was 
defined as persistent or recurrent upper abdominal pain or discomfort over the proceeding 3 
month period. Informed written consent was obtained from all patients participated in the 
trial. Exclusion criteria included patients with a past history of H. pylori eradication therapy; 
previous gastric surgery; patients taking antibiotics, H2 receptor blockers, bismuth or proton 
pump inhibitors in the preceding 4 weeks and blood transfusion within 6 months before 
endoscopy.  
 
Gastric biopsies 
During upper endoscopy, 3 antral biopsies and 2 corpus biopsies were taken. One antral 
biopsy was used for rapid urease test (CLO test) and the rest were sent for histological 
examination of Helicobacter pylori status by hematoxylin and eosin stains. Specimens were 
read by experienced pathologists who were blinded to all clinical information, including the 
CLO test results.  
 
Flexpack HP whole blood test 
After endoscopy, the whole blood test was performed using the Flexpack HP kit (Abbott 
Diagnostic, Illinois, USA, kind gift from Abbott Laboratories Ltd., Hong Kong) according to 
the manufacturer’s instruction. Flexpack HP kits were stored at 40C before use. Individual 
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packs were brought to room temperature shortly before use before removal from the sealed 
pouch. The results were read at 4 minutes by two staffs throughout the study. The validity of 
the test results required agreement between the two staffs. Discrepant results were reported 
as invalid. The test measured human IgG antibodies to H. pylori in whole blood using the 
principle of reverse-flow immunochromatography. Briefly, a sample of whole blood is 
collected from a fingerstick using the Flexpack HP Capillary Tubes included in the kit. The 
sample is applied to the bottom of the sample Pad, which retained the cross-linked blood 
cells and allows the plasma to flow through to the chromatographic Test Strips. The plasma 
and the tracer dye then migrate together through a band of immobilized H. pylori antigen 
(test line). This allows specific antibodies to H. pylori, if present, to bind to the antigen. The 
test card is closed once the plasma and the dye reach the limit line. This initiates the reverse-
flow chromatography step. The conjugate then pass through the test line and the control line 
(immobilized conjugate-specific antibody). The appearance of 2 distinct visible lines (1 
control and 1 test line) indicated a positive test. The appearance of a single line over the 
control line indicates a negative result. The absence of a control line indicates an invalid 
result. 
 
All patients then received a 13C-urea breath test following standard protocol measured by an 
isotope ratio mass spectrometer in the Simon K.Y. Lee Digestive Disease Center, Queen 
Mary Hospital. The definition of H. pylori infection in this study required at least two of the 
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three tests (CLO test, histology and 13C-urea breath test) were positive. The absence of H. 
pylori infection required all three tests to be negative.  This definition was used as the “gold 
standard” in this study. 
 
Statistical analysis 
The statistics used included chi-square test and Fisher’s exact test when appropriate. A P 
value of 0.05 or less is considered statistically significant. The sensitivity, specificity, 
positive predictive value, negative predictive value and overall accuracy were calculated. 
Ninety-five percent confidence intervals were calculated for proportions. 
In order to evaluate the effect of operator familiarity on the accuracy of the test, we arbitrary 
divide the study population into two half according to the entry time into the study. The 
sensitivity and specificity of each half was calculated and compared with each other. 
 
RESULTS 
Thirteen cases were excluded from analysis because they could not be classified according to 
our gold standard for the diagnosis of H. pylori infection, i.e. only 1 positive test out of the 
three tests. Out of the 304 cases, 294 patients gave a valid result for interpretation. The mean 
age of 294 patients was 48 (range 15 to 85) years. There were 99 males and 195 females.  
Most of the patients were ethnic Chinese (98 percent). Four patients were Filipinos. 165 
patients (56 percent) were diagnosed as H. pylori positive by our criteria of gold standard. Of 
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these 165 H. pylori positive patients, 18 (10.9 percent) patients had gastric ulcer, 24 patients 
(14.5 percent) had duodenal ulcer and 9 patients (5.4 percent) had gastro-duodenal erosions. 
Eight patients with H. pylori positive gastric ulcer and nine patients with H. pylori positive 
duodenal ulcer had a negative test by Flexpack HP.  
 
One hundred and twenty-nine patients were H. pylori negative by our gold standard. Of these 
129 patients, 3 patients had gastric ulcer (2.3 percent), 2 patients had duodenal ulcer (1.6 
percent), and 1 patients had gastro-duodenal erosions (0.8 percent). H. pylori status correlate 
strongly with the presence of duodenal ulcer (P=0.001), gastric ulcer (P<0.001) and gastro-
duodenal erosions (P=0.01). 
The sensitivity of the Flexpack HP (whole blood) test using the 13C UBT, CLO and histology 
(2 out of 3) as gold standard was 58.2 percent, specificity of 92.2 percent, positive predictive 
value of 90.6 percent, negative predictive value of 63.3 percent and overall accuracy of 73.1 
percent(Table 1). The sensitivity and specificity of the test for patients under 45 years old 
were 55.4 percent and 95.3 percent respectively. For patients over 45 years old, the 
sensitivity and specificity were 60.4 percent and 89.2 percent respectively(Table 1). The 
prevalence of H. pylori infection was similar between patients under 45 years of age (53.6 
percent) and patients over 45 years of age (58.3 percent) (P = NS). The prevalence of H. 
pylori infection was also similar between male (58.6 percent) and female patients (54.9 
percent) (P = NS). 
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When the study population was divided into two groups according to their chronological 
order of entry into the study, there was no statistical difference between the two groups in 
terms of sensitivity, specificity, positive and negative predictive values, and accuracy (Table 
2). The sex and age distributions were similar between the two groups. In fact, the sensitivity 
appeared higher in the first half (64.9%) when compared to the second half of the study 
(52.2%). Thus operator familiarity did not significantly affect the accuracy of the test. 
 
DISCUSSION 
The Flexpack HP for IgG antibodies to H. pylori in whole blood is advocated as a rapid, 
visually read, qualitative immunochromatographic method for the diagnosis of H. pylori 
infection in primary practice and facilitates referral to specialists or gastroenterologists. The 
accuracy of the test remained an important issue in this regard. The sensitivity and specificity 
of the Flexpack HP (whole blood) test obtained in this study was 58.2% and 92.2% and with 
a positive and negative predictive value of 90.6% and 63.2%. The sensitivity and specificity 
of the test were similar between patient below 45 years of age (55.4%, 95.3%) and patients 
over 45 years of age (60.4%, 89.2%).  
Existing studies show variation in the accuracy of this test, with reported sensitivities ranging 
from 84 to 95 percent and specificities ranging from 74 to 97 percent [13-23]. The study 
population in this study was ethnic Chinese. Our results were quite different from that 
obtained from another study in Chinese population which reported a sensitivity and 
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specificity of 81.8 percent and 83.6 percent respectively [22]. The marked difference 
between our results and the other Chinese study was uncertain. Our study required agreement 
between two staffs to establish a positive or a negative result. Discrepant results were 
reported as invalid. The study reported by Leung et al. used one single observer throughout 
the study[22].  This agreement system used in our study might lower the positivity rate. The 
presence of a faint line in the expected positive position was difficult to interpret and affected 
the overall validity of the test kits. The reporting of borderline cases may be very difficult 
and subject to individual variation. It had also been reported that the lower sensitivity of the 
whole blood test may be partially attributed to challenges associated with collection of blood 
from a finger stick, not the performance of the test as suggested by Sadowski et al.[20]  
Furthermore, methodological dissimilarities exist between different studies. It may account 
for difference in the results obtained [13-23].  
The low sensitivity of the test in this study indicated that the test was insensitive in Chinese 
population. It has been shown that the overall heterogeneity of H. pylori was greater than that 
of most bacteria. [24-26] The use of DNA fingerprinting and restriction fragment length 
polymorphism has demonstrated significant genetic variations among different isolates. A 
previous report has shown substantial differences between the cagA sequences of H. pylori 
strains from China and the Netherlands.[27] Furthermore, the study of geographic 
distribution of vacA alleic types by polymerase chain reaction and reverse hybridization 
assay also showed different geographical prevalence of different H. pylori genotypes.[28] 
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Thus antigenic difference between strains from Asian and western population remains a 
distinct possibility to account for the lower sensitivity of the test in Asian population. Our 
findings are corroborated with the study reported by Leung et al. [22] and the other study 
from Leicester, United Kingdom which has a strong South Asian representation.[29]. On the 
other hand, it is unknown which are the major H. pylori antigens present in the Flexpack HP 
test. And whether CagA is an important part of it. Some other studies have shown  antigenic 
conservation among strains regardless of their geographical origin.  
We observed a higher sensitivity of the test in the first half of the study compared with the 
second. Although this did not reach statistical significance, there appeared to be some 
difference in interpretation with time. One of the possibilities would be the longer shelf time 
for storage of the test kits. The kits were obtained altogether at the beginning of the study and 
stored in our laboratory before use.  
The value of the whole blood test for H. pylori lies on its ability to influence the treatment 
plan and the referral rate in general practice. If endoscopy had been taken only for patients 
with positive tests, nine of the 24 duodenal ulcers and eight of the 18 gastric ulcers would 
have been missed. H. pylori status also had a strong association with gastric cancer particular 
in the Asian population in which the incidence of gastric cancer is high.[30] The low 
sensitivity of the whole blood test to detect H. pylori infection may strongly influence the 
outcome of these patients. Our results suggested that the Flexpack HP may have an 
unacceptable sensitivity rate when used in the general population with dyspepsia.  
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In conclusion, the FlexPack HP whole blood test showed good specificity but lacked 
sensitivity in Chinese population. It does not provide the required accuracy to be used in 
general practice setting. 
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Table 1. Sensitivity, specificity, positive and negative predictive values, and accuracy with 
95 percent confidence interval of Flexpack HP whole blood test using C13 urea breath test, 
CLO and histology (2 out of 3) as golden standard 
 
 
 
           
 
Overall Age < 45 Age > 45 
Sensitivity   (%) 
                                                    
58.2 
(50-66)* 
55.4 
(43-67) 
60.4 
(50-71) 
 
Specificity (%) 
 
92.2 
(86-96) 
95.3 
(87-99) 
89.2 
(79-96) 
 
Positive predictive value 
(%) 
90.6 
(83-95) 
93.2 
(81-99) 
88.7 
(78-95) 
 
Negative predictive value 
(%) 
63.2 
(56-70) 
64.9 
(54-74) 
61.7 
(51-72) 
 
Accuracy (%) 
 
73.1 
(68-78) 
73.9 
(66-81) 
72.4 
(65-79) 
 
                                                                                                            
* 95 percent confidence intervals shown in brackets. 
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Table 2. Sensitivity, specificity, positive and negative predictive values, and accuracy with 
95 percent confidence interval of Flexpack HP whole blood test when the study population 
was divided into two halves according to their chronological entry into the study  
 
 
 
 
                
 
First half Second half 
Sex (M/F) 
 
51/100 50/103 
Mean Age  
 
47.9 47.7 
Sensitivity   (%) 
                                                    
64.9 
(53-75)* 
52.3 
(41-63) 
Specificity (%) 
 
88.1 
(78-95) 
96.8 
(89-100) 
Positive predictive value 
(%) 
86.2 
(75-94) 
95.8 
(86-99) 
Negative predictive value 
(%) 
68.6 
(58-78) 
58.8 
(49-68) 
Accuracy (%) 
 
75.7 
(68-82) 
 
70.7 
(63-78) 
* 95 percent confidence intervals shown in brackets. 
 
 
